关注
Markus Schlaich
Markus Schlaich
Dobney Hypertension Centre - Royal Perth Hospital Campus, University of Western Australia
在 uwa.edu.au 的电子邮件经过验证
标题
引用次数
年份
Shop-to-stop hypertension: A multicenter cluster-randomized controlled trial protocol to improve screening and text message follow-up of adults with high blood pressure at …
SR Gnanenthiran, M Barnhart, I Tan, M Zeng, E O'Hagan, C Gianacas, ...
Contemporary Clinical Trials, 107610, 2024
2024
Sympathetic Activation Promotes Sodium Glucose Co-Transporter-1 Protein Expression in Rodent Skeletal Muscle
JR Matthews, LY Herat, MP Schlaich, VB Matthews
Preprints, 2024
2024
Sympathetic Pathophysiology in Hypertension Origins: The Path to Renal Denervation
MD Esler, JW Osborn, MP Schlaich
Hypertension 81 (6), 1194-1205, 2024
2024
Long-Term Blood Pressure Reductions Following Catheter-Based Renal Denervation: A Systematic Review and Meta-Analysis
G Sesa-Ashton, JM Nolde, I Muente, R Carnagarin, VG Macefield, ...
Hypertension 81 (6), e63-e70, 2024
12024
Ambulatory blood pressure after 12 weeks of quadruple combination of quarter doses of blood pressure medication vs. standard medication
JM Nolde, E Atkins, S Marschner, GS Hillis, J Chalmers, L Billiot, ...
Journal of Hypertension 42 (6), 1009-1018, 2024
12024
Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the …
M Naghavi, KL Ong, A Aali, HS Ababneh, YH Abate, C Abbafati, ...
The Lancet 403 (10440), 2100-2132, 2024
352024
Targeting the sympathetic nervous system with the selective imidazoline receptor agonist moxonidine for the management of hypertension: an international position statement
MP Schlaich, K Tsioufis, S Taddei, C Ferri, M Cooper, A Sindone, ...
Journal of Hypertension, 10.1097, 2024
2024
Participants’ views of ultra-low dose combination therapy for high blood pressure: a mixed-methods study from the QUARTET trial
JG Kovoor, CK Chow, A Salam, R Webster, L Shiel, MR Nelson, ...
Journal of Human Hypertension, 1-7, 2024
2024
Ocular biomarkers: useful incidental findings by deep learning algorithms in fundus photographs
E Martin, AG Cook, SM Frost, AW Turner, FK Chen, IL McAllister, ...
Eye, 1-8, 2024
2024
REGIONAL VARIATION OF AGE-RELATED BLOOD PRESSURE TRAJECTORIES AND THEIR ASSOCIATION WITH BLOOD PRESSURE CONTROL RATES, DISABILITY-ADJUSTED LIFE YEARS AND DEATH
J Nolde, T Beaney, R Carnagarin, G Stergiou, N Poulter, A Schutte, ...
Journal of Hypertension 42 (Suppl 1), e172, 2024
2024
NON-LINEAR RELATIONSHIPS BETWEEN WITHIN-VISIT BLOOD PRESSURE VARIABILITY, MEAN BLOOD PRESSURE, SEX, AND AGE IN UNTREATED MAY MEASURMENT MONTH 2019 PARTICIPANTS
G Kerr, T Beaney, M Schlaich, A Schutte, G Stergiou, N Poulter
Journal of Hypertension 42 (Suppl 1), e79, 2024
2024
BLOOD PRESSURE VARIABILITY AND HISTORY OF CARDIOVASCULAR EVENTS IN MAY MEASUREMENT MONTH 2019 PARTICIPANTS
G Kerr, T Beaney, M Schlaich, A Schutte, G Stergiou, N Poulter
Journal of Hypertension 42 (Suppl 1), e79, 2024
2024
RENAL DENERVATION RESULTS IN SUBSTANTIAL NOCTURNAL BP REDUCTION IN PATIENTS WITH A REVERSED DIPPING PATTERN
F Mahfoud, M Schlaich, K Narkiewicz, L Ruilope, B Williams, R Schmieder, ...
Journal of Hypertension 42 (Suppl 1), e136-e137, 2024
2024
EFFECT OF HIGH DOSE APROCITENTAN IN PATIENTS WITH RESISTANT HYPERTENSION NOT CONTROLLED BY LOW DOSE
K Narkiewicz, P Danaietash, A Gimona, G Kania, I Kantola, ...
Journal of Hypertension 42 (Suppl 1), e112-e113, 2024
2024
COMPARING BLOOD PRESSURE CONTROL TARGETS GLOBALLY: AN ANALYSIS OF THE MAY MEASUREMENT MONTH 2022 CAMPAIGN IN 60 COUNTRIES
T Beaney, G Kerr, M Schlaich, A Schutte, G Stergiou, N Poulter
Journal of Hypertension 42 (Suppl 1), e26, 2024
2024
THREE-YEAR NIGHTTIME BLOOD PRESSURE REDUCTIONS AFTER RADIOFREQUENCY RENAL DENERVATION IN PATIENTS WITH UNCONTROLLED HYPERTENSION AND CHRONIC KIDNEY DISEASE
M Schlaich, F Mahfoud, K Narkiewicz, L Ruilope, B Williams, ...
Journal of Hypertension 42 (Suppl 1), e18, 2024
2024
BLOOD PRESSURE CONTROL WITH APROCITENTAN IN RESISTANT HYPERTENSION
K Narkiewicz, P Danaietash, G Kania, I Kantola, F Martinez-garcia, ...
Journal of Hypertension 42 (Suppl 1), e12, 2024
2024
F-5| Long-term Outcomes Following Radiofrequency Renal Denervation: Meta-analysis of 18 Reports with Patient Level Data from the Global Symplicity Registry DEFINE
DE Kandzari, F Mahfoud, RE Schmieder, L Ruilope, K Narkiewicz, ...
Journal of the Society for Cardiovascular Angiography & Interventions 3 (5), 2024
2024
Therapeutic Inertia With Initial Low-Dose Quadruple Combination Therapy for Hypertension: Results From the QUARTET Trial
N Wang, A Von Huben, S Marschner, MR Nelson, JM Nolde, MP Schlaich, ...
Hypertension 81 (5), 1087-1094, 2024
2024
Salt sensitivity risk derived from nocturnal dipping and 24-h heart rate predicts long-term blood pressure reduction following renal denervation
G Sesa-Ashton, R Carnagarin, JM Nolde, I Muente, R Lee, VG Macefield, ...
Journal of Hypertension 42 (5), 922-927, 2024
2024
系统目前无法执行此操作,请稍后再试。
文章 1–20